- Home
- TECX vs CION Comparison
TECX vs CION Comparison
Compare TECX & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- CION
- Stock Information
- Founded
- TECX 2019
- CION 2011
- Country
- TECX United States
- CION United States
- Employees
- TECX N/A
- CION N/A
- Industry
- TECX
- CION Finance/Investors Services
- Sector
- TECX
- CION Finance
- Exchange
- TECX Nasdaq
- CION Nasdaq
- Market Cap
- TECX 647.7M
- CION 634.5M
- IPO Year
- TECX 2018
- CION N/A
- Fundamental
- Price
- TECX $44.89
- CION $11.54
- Analyst Decision
- TECX Strong Buy
- CION Hold
- Analyst Count
- TECX 5
- CION 2
- Target Price
- TECX $72.25
- CION $12.25
- AVG Volume (30 Days)
- TECX 140.0K
- CION 212.1K
- Earning Date
- TECX 11-07-2024
- CION 11-07-2024
- Dividend Yield
- TECX N/A
- CION 12.13%
- EPS Growth
- TECX N/A
- CION 50.69
- EPS
- TECX N/A
- CION 1.48
- Revenue
- TECX N/A
- CION $254,537,000.00
- Revenue This Year
- TECX N/A
- CION $0.53
- Revenue Next Year
- TECX N/A
- CION N/A
- P/E Ratio
- TECX N/A
- CION $7.82
- Revenue Growth
- TECX N/A
- CION 3.26
- 52 Week Low
- TECX $1.40
- CION $10.52
- 52 Week High
- TECX $48.63
- CION $12.69
- Technical
- Relative Strength Index (RSI)
- TECX 61.61
- CION 46.55
- Support Level
- TECX $37.50
- CION $11.34
- Resistance Level
- TECX $48.63
- CION $11.54
- Average True Range (ATR)
- TECX 3.47
- CION 0.21
- MACD
- TECX -0.63
- CION 0.00
- Stochastic Oscillator
- TECX 66.40
- CION 42.42
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.
About CION CION Investment Corporation
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies.